Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Hepatitis

Free Subscription 15.12.2025 1 Am J Gastroenterol 1 Arch Virol 2 BMC Gastroenterol 1 BMJ 1 Clin Infect Dis 1 Gut 1 Hepatology 1 J Infect Dis 1 J Med Virol 5 J Viral Hepat 1 J Virol 1 Nature 4 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. LI J, Liu JK, Chau A, Linden S, et al
   Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naive chronic hepatitis B: A REAL-B study.
   Am J Gastroenterol. 2025 Dec 12. doi: 10.14309/ajg.0000000000003881.
   PubMed         Abstract available
   
   

   
   Arch Virol

2. NOWAK K, Lupina K, Ilkiewicz L, Kalisz A, et al
   When serology misleads: cross-reactivity in acute hepatitis.
   Arch Virol. 2025;171:12.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. AREGA B, Tefera E, Mesfin K, Achame D, et al
   Hepatitis B and C infections, and co-infections screening among patients attending a tertiary hospital in Addis Ababa, Ethiopia: a retrospective database study.
   BMC Gastroenterol. 2025 Dec 12. doi: 10.1186/s12876-025-04541.
   PubMed        
   
   
4. LI L, Li H, Zhao Y, Shi L, et al
   The ratio of GGT to PLT indices is a predictive factor for the progression of liver fibrosis in NA-treated chronic hepatitis B patients with advanced fibrosis plus PEG-IFN alpha-2a therapy: a case-control study.
   BMC Gastroenterol. 2025 Dec 10. doi: 10.1186/s12876-025-04508.
   PubMed         Abstract available
   
   

   
   BMJ

5. TANNE JH
   US vaccination: Hepatitis jab changes for newborns as Trump orders review of entire childhood schedule.
   BMJ. 2025;391:r2588.
   PubMed        
   
   

   
   Clin Infect Dis

6. MENDLOWITZ AB, Flemming JA, Kushner T, Wong WWL, et al
   Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy.
   Clin Infect Dis. 2025 Dec 9:ciaf578. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Gut

7. WU X, Quan D, Li W, Wisskirchen K, et al
   Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.
   Gut. 2025 Aug 12:gutjnl-2025-335456. doi: 10.1136/gutjnl-2025-335456.
   PubMed         Abstract available
   
   

   
   Hepatology

8. 
   Updated AASLD Guidelines for Chronic Hepatitis B Treatment.
   Hepatology. 2025 Nov 4. doi: 10.1097/HEP.0000000000001607.
   PubMed        
   
   

   
   J Infect Dis

9. REED JL, Butzler MA, Hawkins CA, Manabe YC, et al
   Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH(R) Rapid PCR System.
   J Infect Dis. 2025 Dec 10:jiaf608. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Med Virol

10. NOBILE AL, Adri AS, Usuda JN, Vale FYND, et al
    The Neuroimmunome of Hepatitis Patients Associates With Disease Severity.
    J Med Virol. 2025;97:e70742.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

11. BAUMGARTEN T, Lehmann F, Senff T, Slanina H, et al
    Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-Up.
    J Viral Hepat. 2026;33:e70111.
    PubMed         Abstract available
    
    
12. MA H, Zheng J, Huang L, Qiu Z, et al
    Single-Arm Meta-Analysis and Systematic Review on Clinical Cure of Chronic Hepatitis B After Haematopoietic Stem Cell Transplantation: Immunoregulatory Mechanisms and Clinical Translational Insights.
    J Viral Hepat. 2026;33:e70114.
    PubMed         Abstract available
    
    
13. 
    Correction to 'A Contactless Cure: Leveraging Telehealth to Improve Hepatitis C Treatment at a Safety-Net Hospital'.
    J Viral Hepat. 2026;33:e70117.
    PubMed        
    
    
14. LI C, Lin L, Zhou P, Cai H, et al
    Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.
    J Viral Hepat. 2026;33:e70115.
    PubMed         Abstract available
    
    
15. FEELEMYER J, Ban FK, Braithwaite RS, Bhattacharya D, et al
    Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response.
    J Viral Hepat. 2026;33:e70116.
    PubMed         Abstract available
    
    

    
    J Virol

16. TILLER K, Williams ST, Wang B, Tian D, et al
    Reactive oxygen species promotion drives auranofin's antiviral activity against hepatitis E virus.
    J Virol. 2025 Dec 9:e0191725. doi: 10.1128/jvi.01917.
    PubMed         Abstract available
    
    

    
    Nature

17. LENHARO M, Ledford H
    Hepatitis B vaccine guidance set to be rolled back for US babies: what the science says.
    Nature. 2025 Dec 5. doi: 10.1038/d41586-025-03937.
    PubMed        
    
    

    
    PLoS One

18. LI Y, Liu B, Hu G, Zhou T, et al
    Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis.
    PLoS One. 2025;20:e0337060.
    PubMed         Abstract available
    
    
19. STANDL F, Senger L, Stich H
    Prevalence of sexually transmitted infections and immunization status among registered sex workers: A pilot study in lower Bavaria, Germany.
    PLoS One. 2025;20:e0338710.
    PubMed         Abstract available
    
    
20. ALQAHTANI SA, AlMuhaidib S, Raptis DA, Al-Hamoudi WK, et al
    Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia.
    PLoS One. 2025;20:e0338438.
    PubMed         Abstract available
    
    
21. CHI G, Che Y, Pei J, Li X, et al
    Decoding the distinct immune landscape and possible regulatory mechanisms of autoimmune hepatitis through integrated single-cell and bulk RNA sequencing.
    PLoS One. 2025;20:e0335605.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

22. WANG Y, Wu S, Li X, Qiao L, et al
    Antiviral and immune modulatory activities of STING agonists in a mouse model of persistent hepatitis B virus infection.
    PLoS Pathog. 2025;21:e1013709.
    PubMed         Abstract available
    
    
23. GUNAWARDENE CD, Pandey I, Chatterjee S, Penaflor-Tellez Y, et al
    Heterologous expression of HCoV-HKU1 ORF 7b by mouse hepatitis virus protects against severe disease during murine infection.
    PLoS Pathog. 2025;21:e1013148.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. WANG Y, Tian H, Shi N, Wu C, et al
    The prion-like characteristic of ORF3 contributes to virion release and pathogenesis of hepatitis E virus.
    Proc Natl Acad Sci U S A. 2025;122:e2511801122.
    PubMed         Abstract available
    
    

    
    Vaccine

25. GRACE A, Schick V, Quan FT, Troisi C, et al
    Hepatitis B vaccination series completion among residents of low-income housing in Texas: An exploratory analysis of demographic and clinical factors.
    Vaccine. 2026;70:128037.
    PubMed         Abstract available
    
    

    
    Virology

26. CHANDANE-TAK M, Suneesh NS, Mukherjee S, Khan AA, et al
    Network-based integration of hsa-miR-150-5p reveals key regulatory roles in HIV-HCV coinfection and HCV-associated hepatocellular carcinoma.
    Virology. 2025;615:110747.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.